HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 262 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $671,391,065 | +10.6% | 5,803,363 | -1.6% | 0.34% | +13.0% |
Q2 2023 | $606,772,934 | +114799.5% | 5,899,591 | +21.9% | 0.30% | -1.0% |
Q1 2023 | $528,090 | +21.2% | 4,838,654 | +26.4% | 0.30% | +25.7% |
Q4 2022 | $435,585 | -98.1% | 3,827,636 | +948.4% | 0.24% | +1753.8% |
Q3 2022 | $22,596,000 | -65.5% | 365,097 | -55.5% | 0.01% | -68.3% |
Q2 2022 | $65,466,000 | -57.7% | 820,786 | -44.2% | 0.04% | -50.0% |
Q1 2022 | $154,631,000 | +8.4% | 1,469,733 | +11.1% | 0.08% | +13.9% |
Q4 2021 | $142,614,000 | +105.4% | 1,323,438 | +108.8% | 0.07% | +71.4% |
Q3 2021 | $69,421,000 | +29.2% | 633,752 | +10.4% | 0.04% | +27.3% |
Q2 2021 | $53,750,000 | +544.7% | 574,011 | +533.7% | 0.03% | +450.0% |
Q1 2021 | $8,337,000 | -56.7% | 90,584 | -65.5% | 0.01% | -57.1% |
Q4 2020 | $19,233,000 | -58.0% | 262,922 | -55.3% | 0.01% | -75.0% |
Q3 2020 | $45,742,000 | +98.1% | 588,848 | +41.8% | 0.06% | +75.0% |
Q2 2020 | $23,087,000 | +1458.9% | 415,376 | +730.8% | 0.03% | +966.7% |
Q1 2020 | $1,481,000 | -86.5% | 50,000 | -83.4% | 0.00% | -78.6% |
Q4 2019 | $10,930,000 | -60.1% | 301,928 | -70.0% | 0.01% | -67.4% |
Q3 2019 | $27,400,000 | -30.5% | 1,006,265 | -38.6% | 0.04% | -27.1% |
Q2 2019 | $39,425,000 | – | 1,638,621 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |